SCHEMBL29978619

SCHEMBL29978619

CN(C)S(=O)(=O)c1ccc(S(=O)(=O)Nc2cccc(Cl)c2N2CCC(O)CC2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCOLN2 Q8IZK6 1/20 0.77
LMNA P02545 4/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.42
PIK3CA P42336 1/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
TSHR P16473 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
HTT P42858 2/20 0.38
GAA P10253 2/20 0.38
USP2 O75604 1/20 0.38
ALOX15 P16050 1/20 0.38
OPRK1 P41145 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23057083 0.90 MCOLN2 (0.78) MCOLN2LMNAALDH1A1KDM4EHPGD
SCHEMBL23057211 0.87 MCOLN2 (1.00) MCOLN2LMNAALDH1A1KDM4EHPGD
SCHEMBL23057166 0.82 MCOLN3 (0.52) MCOLN2LMNAALDH1A1KDM4EHPGD
SCHEMBL29978845 0.82 MCOLN2 (0.66) MCOLN2LMNAALDH1A1KDM4EHPGD
SCHEMBL23057168 0.82 MCOLN2 (0.66) MCOLN2LMNAALDH1A1KDM4EHPGD
SCHEMBL31036862 0.80 MCOLN2 (0.63) MCOLN2LMNAALDH1A1KDM4EHPGD
SCHEMBL29947162 0.80 MCOLN2 (0.62) MCOLN2LMNAALDH1A1KDM4EHPGD
SCHEMBL23057095 0.80 MCOLN2 (0.59) MCOLN2LMNAALDH1A1KDM4EHPGD
SCHEMBL23057222 0.79 ALDH1A1 (0.49) MCOLN2LMNAALDH1A1KDM4EHPGD
SCHEMBL23057320 0.78 MCOLN2 (0.60) MCOLN2LMNAALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 MCOLN2 2/4885LMNA 581/4885ALDH1A1 1368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.